<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.channelnewsasia.com/news/world/beigene-prices-lymphoma-drug-at-us-12-935-for-a-30-day-supply-12099290"/>
    <meta property="og:site_name" content="CNA"/>
    <meta property="article:published_time" content="2019-11-16T06:42:00+00:00"/>
    <meta property="og:title" content="BeiGene prices lymphoma drug at US$12,935 for a 30-day supply"/>
    <meta property="og:description" content="REUTERS: China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at US$12,935 for a 30-day supply."/>
  </head>
  <body>
    <article>
      <h1>BeiGene prices lymphoma drug at US$12,935 for a 30-day supply</h1>
      <address>
        <time datetime="2019-11-16T06:42:00+00:00">16 Nov 2019, 06:42</time>
      </address>
      <p>REUTERS: China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at US$12,935 for a 30-day supply.</p>
      <p>The U.S. Food and Drug Administration on Thursday approved the drug, giving a boost to the company's strategy of largely using data from studies held outside the United States.</p>
      <aside>Advertisement</aside>
      <aside>Advertisement</aside>
      <p>Brokerage Cowen &amp; Co expects peak global sales of Brukinsa to be US$836 million across all indications, and US$90 million in mantle cell lymphoma.</p>
      <p>(Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren Daniel)</p>
      <footer>Source: Reuters</footer>
    </article>
  </body>
</html>